{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T23:26:53Z","timestamp":1780961213545,"version":"3.54.1"},"reference-count":41,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["F30 HL151182"],"award-info":[{"award-number":["F30 HL151182"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL138628"],"award-info":[{"award-number":["R01 HL138628"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL138628-01A1S1"],"award-info":[{"award-number":["R01 HL138628-01A1S1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["T32 HL144909"],"award-info":[{"award-number":["T32 HL144909"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["F30 HD102093"],"award-info":[{"award-number":["F30 HD102093"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2022,8,19]]},"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Individuals with sarcoidosis are at higher risk for infection owing to underlying disease pathogenesis and need for immunosuppressive treatment. Current knowledge as to how subjects with sarcoidosis respond to different forms of vaccination is limited. We examined quantitative and functional antibody response to COVID-19 vaccination in infection-naive subjects with and without sarcoidosis.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Our prospective cohort study recruited 14 subjects with biopsy-proven sarcoidosis and 27 age\u2013sex matched controls who underwent a two-shot series of the BNT162b2 mRNA vaccine at the University of Illinois at Chicago. Baseline, 4-week and 6-month trimer spike protein IgG and neutralising antibody (nAb) titres were assessed. Correlation and multivariate regression analysis was conducted.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Sarcoidosis subjects had a significant increase in short-term antibody production to a level comparable to controls; however, IgG titres significantly declined back to baseline levels by 6\u2005months. Corresponding neutralising assays revealed robust nAb titres in sarcoidosis subjects that persisted at 6\u2005months. A significant and strong correlation between IgG and nAb titres across all time points was observed in the control group. However within the sarcoidosis group, a significant but weak correlation between antibody levels was found. Overall, IgG levels were poor predictors of nAb titres at short- or long-term time points.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Sarcoidosis subjects exhibit nAb induced by the BNT162b2 mRNA SARS-CoV-2 vaccine at levels comparable to controls that persists at 6\u2005months indicating conferred immunity. Trimer IgG levels are poor predictors of nAb in subjects with sarcoidosis. Studies of further antibody immunoglobulins and subtypes warrant investigation.<\/jats:p>\n<\/jats:sec>","DOI":"10.1183\/23120541.00025-2022","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T14:11:46Z","timestamp":1663337506000},"page":"00025-2022","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Trimer IgG and neutralising antibody response to COVID-19 mRNA vaccination in individuals with sarcoidosis"],"prefix":"10.1183","volume":"9","author":[{"given":"Christen L.","family":"Vagts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Shin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7424-2710","authenticated-orcid":false,"given":"Christian","family":"Ascoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4492-2221","authenticated-orcid":false,"given":"Jessica M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth A.","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1214-8411","authenticated-orcid":false,"given":"Nandini","family":"Sarup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha R.","family":"Warpecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Edafetanure-Ibeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5795-074X","authenticated-orcid":false,"given":"Md-Ruhul","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasmin","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Ghassemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2215-0221","authenticated-orcid":false,"given":"Nadera J.","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6936-103X","authenticated-orcid":false,"given":"Patricia W.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"2024101710032119000_9.1.00025-2022.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"2024101710032119000_9.1.00025-2022.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"2024101710032119000_9.1.00025-2022.3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1165\/rcmb.2017-0207OC","article-title":"A circulating MicroRNA signature serves as a diagnostic and prognostic indicator in sarcoidosis.","volume":"58","author":"Ascoli","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2024101710032119000_9.1.00025-2022.4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009088"},{"key":"2024101710032119000_9.1.00025-2022.5","doi-asserted-by":"crossref","first-page":"3642832","DOI":"10.1155\/2017\/3642832","article-title":"Local and systemic CD4+ T cell exhaustion reverses with clinical resolution of pulmonary sarcoidosis","volume":"2017","author":"Hawkins","year":"2017","journal-title":"J Immunol Res"},{"key":"2024101710032119000_9.1.00025-2022.6","doi-asserted-by":"crossref","first-page":"e8846","DOI":"10.1097\/MD.0000000000008846","article-title":"Severe infections in sarcoidosis: incidence, predictors and long-term outcome in a cohort of 585 patients","volume":"96","author":"Dur\u00e9ault","year":"2017","journal-title":"Medicine"},{"key":"2024101710032119000_9.1.00025-2022.7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1513\/AnnalsATS.201610-750OC","article-title":"Sarcoidosis increases risk of hospitalized infection. A population-based study, 1976-2013.","volume":"14","author":"Ungprasert","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"2024101710032119000_9.1.00025-2022.8","first-page":"e2020009","article-title":"Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire","volume":"37","author":"Baughman","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024101710032119000_9.1.00025-2022.9","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201511-760OC"},{"key":"2024101710032119000_9.1.00025-2022.10","first-page":"3","article-title":"Results of tetanus vaccination in sarcoidosis","volume":"29","author":"Seyhan","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024101710032119000_9.1.00025-2022.11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1159\/000067471","article-title":"Results of hepatitis B vaccination in sarcoidosis","volume":"67","author":"Mert","year":"2000","journal-title":"Respiration"},{"key":"2024101710032119000_9.1.00025-2022.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1750-2659.2011.00290.x"},{"key":"2024101710032119000_9.1.00025-2022.13","unstructured":"Payne S . Viruses: from Understanding to Investigation. 1st Edn. Boston, MA: Elsevier, 2017."},{"key":"2024101710032119000_9.1.00025-2022.14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.3685"},{"key":"2024101710032119000_9.1.00025-2022.15","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.1016\/S2665-9913(21)00212-5","article-title":"The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study","volume":"3","author":"Mahil","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"2024101710032119000_9.1.00025-2022.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.1834"},{"key":"2024101710032119000_9.1.00025-2022.17","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.170710"},{"key":"2024101710032119000_9.1.00025-2022.18","doi-asserted-by":"crossref","first-page":"672028","DOI":"10.3389\/fmed.2021.672028","article-title":"COVID-19 and sarcoidosis, readiness for vaccination: challenges and opportunities.","volume":"8","author":"Manansala","year":"2021","journal-title":"Front Med"},{"key":"2024101710032119000_9.1.00025-2022.19","first-page":"87","article-title":"Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy","volume":"37","author":"Syed","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024101710032119000_9.1.00025-2022.20","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of sarcoidosis and other granulomatous disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024101710032119000_9.1.00025-2022.21","doi-asserted-by":"crossref","first-page":"e0209060","DOI":"10.1371\/journal.pone.0209060","article-title":"A computational solution to improve biomarker reproducibility during long-term projects","volume":"14","author":"Feng","year":"2019","journal-title":"PLoS One"},{"key":"2024101710032119000_9.1.00025-2022.22","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1038\/s41596-020-0394-5","article-title":"Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay","volume":"15","author":"Nie","year":"2020","journal-title":"Nat Protoc"},{"key":"2024101710032119000_9.1.00025-2022.23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/mps1010008","article-title":"Pseudotype neutralization assays: from laboratory bench to data analysis","volume":"1","author":"Ferrara","year":"2018","journal-title":"Methods Protoc"},{"key":"2024101710032119000_9.1.00025-2022.24","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/infdis\/jiaa784","article-title":"Role of immunoglobulin M and A antibodies in the neutralization of severe acute respiratory syndrome coronavirus 2","volume":"6","author":"Klingler","year":"2021","journal-title":"J Infect Dis"},{"key":"2024101710032119000_9.1.00025-2022.25","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd2223"},{"key":"2024101710032119000_9.1.00025-2022.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0474-z"},{"key":"2024101710032119000_9.1.00025-2022.27","doi-asserted-by":"publisher","DOI":"10.5937\/jomb0-32373"},{"key":"2024101710032119000_9.1.00025-2022.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.058"},{"key":"2024101710032119000_9.1.00025-2022.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2020.112937"},{"key":"2024101710032119000_9.1.00025-2022.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84733-5"},{"key":"2024101710032119000_9.1.00025-2022.31","first-page":"71","article-title":"[Clinical value of the determination of isoenzymes of malate and lactate dehydrogenase in the urine in chronic kidney diseases in children]","volume":"0","author":"Volkova","year":"1974","journal-title":"Pediatriia"},{"key":"2024101710032119000_9.1.00025-2022.32","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/v14020312","article-title":"Differential dynamics of SARS-CoV-2 binding and functional antibodies upon BNT162b2 vaccine: a 6-month follow-up","volume":"14","author":"Matusali","year":"2022","journal-title":"Viruses"},{"key":"2024101710032119000_9.1.00025-2022.33","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0096-x"},{"key":"2024101710032119000_9.1.00025-2022.34","doi-asserted-by":"crossref","first-page":"595077","DOI":"10.3389\/fmed.2021.595077","article-title":"Unsupervised clustering reveals sarcoidosis phenotypes marked by a reduction in lymphocytes relate to increased inflammatory activity on 18FDG-PET\/CT","volume":"8","author":"Vagts","year":"2021","journal-title":"Front Med"},{"key":"2024101710032119000_9.1.00025-2022.35","first-page":"72","article-title":"Serum B cell activating factor (BAFF) and sarcoidosis activity","volume":"36","author":"Hashemzadeh","year":"2021","journal-title":"Arch Rheumatol"},{"key":"2024101710032119000_9.1.00025-2022.36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41598-020-57741-0","article-title":"Imbalance in B cell and T follicular helper cell subsets in pulmonary sarcoidosis","volume":"10","author":"Kudryavtsev","year":"2020","journal-title":"Sci Rep"},{"key":"2024101710032119000_9.1.00025-2022.37","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.autrev.2018.04.004","article-title":"Vimentin as antigenic target in autoimmunity: a comprehensive review","volume":"17","author":"Musaelyan","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2024101710032119000_9.1.00025-2022.38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043588"},{"key":"2024101710032119000_9.1.00025-2022.39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110036"},{"key":"2024101710032119000_9.1.00025-2022.40","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s10875-021-00997-6","article-title":"Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal betacoronaviruses","volume":"41","author":"Hicks","year":"2021","journal-title":"J Clin Immunol"},{"key":"2024101710032119000_9.1.00025-2022.41","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e3181f7dbe8"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00025-2022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:20:51Z","timestamp":1740374451000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00025-2022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,3]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1183\/23120541.00025-2022"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00025-2022","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]}}}